Labcorp (NYSE: LH) sets Q3 2025 earnings release and webcast call

Rhea-AI Filing Summary

Labcorp Holdings Inc. announced that it will release its third-quarter 2025 financial results before the market opens on Tuesday, October 28, 2025. The company will host a conference call and webcast at 9 a.m. ET the same day to discuss the results, and the earnings press release with related financial information will be posted on the Labcorp Investor Relations website.

The announcement is furnished through a press release dated September 25, 2025, which is included as Exhibit 99.1 to this report and incorporated by reference.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

0000920148false00009201482025-09-252025-09-25

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

September 25, 2025

(Date of earliest event reported)

LABCORP HOLDINGS INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware

1-11353

99-2588107

(State or other jurisdiction of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

358 South Main Street

Burlington

,

North Carolina

27215

(Address of principal executive offices)

(Zip Code)

(Registrant’s telephone number including area code) 336-229-1127

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act.

Title of each class

Trading Symbol

Name of exchange on which registered

Common Stock, $0.10 par value

LH

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).             

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on September 25, 2025 that it will release its financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025, and will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

A copy of the press release dated September 25, 2025 is furnished as Exhibit 99.1 hereto and incorporated by reference herein.

Item 9.01			Financial Statements and Exhibits.
Exhibit			Exhibit Name
Exhibit 99.1			Press release dated September 25, 2025 issued by Labcorp Holdings Inc.
Exhibit 104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LABCORP HOLDINGS INC.

Registrant

Date: September 25, 2025			By:			/s/ SANDRA D. VAN DER VAART
						Sandra D. van der Vaart
						Executive Vice President, Chief Legal Officer and Corporate Secretary

FAQ

What did Labcorp (LH) announce in this 8-K filing?

Labcorp Holdings Inc. announced plans to release its third-quarter 2025 financial results and to host a conference call and webcast to discuss those results.

When will Labcorp (LH) report its Q3 2025 financial results?

Labcorp will release its Q3 2025 financial results before the market opens on Tuesday, October 28, 2025.

What time is Labcorps Q3 2025 earnings conference call and webcast?

The Q3 2025 earnings conference call and webcast will begin at 9 a.m. Eastern Time on October 28, 2025.

Where can investors access Labcorp (LH) Q3 2025 earnings materials?

The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

What is Exhibit 99.1 in this Labcorp (LH) 8-K?

Exhibit 99.1 is the press release dated September 25, 2025 issued by Labcorp Holdings Inc. regarding the upcoming Q3 2025 earnings release and call.

Does this Labcorp (LH) filing include the actual Q3 2025 results?

No. This report announces the timing of the Q3 2025 results release and related call, and furnishes the press release describing that schedule.